IMMUNOSUPPRESSION IN PROLONGING TRANSGENE EXPRESSION: CYSTIC FIBROSIS
IMMUNOSUPPRESSION IN PROLONGING TRANSGENE EXPRESSION: CYSTIC FIBROSIS
批准号:
6116207
负责人:
GARY B BASKIN
金额:
$16.14万
依托单位国家:
美国
项目类别:
财政年份:
1999
资助国家:
美国
项目状态:
已结题
起止时间:
1999-05-01 至 2000-04-30
中文摘要
我们测试了人源化非消耗性抗CD 4的假设
抗体(OKT 4acdr 3)可延长腺病毒介导的基因表达
在恒河猴的肺里 我们用12 mg/kg OKT 4a IV处理恒河猴
第-1天至第+11天每天给药。 在第0天,给予动物5 x 1010
pfu的AdCMVLacZ进入肺。 一个亚组继续在
通过将AdCMVLacZ施用到细胞中的第二基因转移方案,
其他肺 有较少的炎症和更多的基因转移,
抗CD 4处理的动物。 二次基因转移效率不高,
在任何一组中完成。 OKT 4acdr 3阻断T细胞活化,
腺病毒和lacZ和延长的基因表达。 OKT 4cdr 3没有
减弱B细胞反应。 可能OKT 4a专门阻止了
产生TH 1反应。 使用抗-CD 4抗体的研究
啮齿类动物已经在幼稚动物中进行。 我们所有的猴子
基线非中和抗腺病毒抗体。 因此,另
一种假设是,在大脑中,少量的记忆B细胞可以增殖,
缺乏CD 4依赖的帮助。 由于大多数患者
抗腺病毒抗体,我们必须辨别正确的假设,
重复性基因转移有待开发。 囊性纤维化
基金会,J. Kolls,PI,$150,000 Publications无
英文摘要
We tested the hypothesis that a humanized non-depleting anti-CD4
antibody (OKT4acdr3) would prolong adenoviral-mediated gene expression
in rhesus lungs. We treated rhesus macaques with 12 mg/kg OKT4a IV
daily on days -1 to day +11. On day 0, animals were given 5 x 1010
pfu of AdCMVLacZ into the lung. A subgroup was continued on a
secondary gene transfer protocol by administering AdCMVLacZ into the
other lung. There was less inflammation and greater gene transfer in
anti-CD4 treated animals. Secondary gene transfer was not efficiently
accomplished in either group. OKT4acdr3 blocked T-cell activation to
adenovirus and lacZ and prolonged gene expression. OKT4cdr3 did not
attenuate B-cell responses. Possibly OKT4a specifically blocked the
generation of a TH1 response. Studies using anti-CD4 antibodies in
rodents have been performed in naive animals. All our monkeys had
baseline non-neutralizing anti-adenoviral antibodies. Thus, another
hypothesis is that low numbers of memory B-cells can proliferate in
the absence of CD4 dependent help. Since most patients have
anti-adenoviral antibodies, we must discern the correct hypothesis for
repetitive gene transfer to be developed. FUNDING Cystic Fibrosis
Foundation, J. Kolls, PI, $150,000 PUBLICATIONS None
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
AAV AS VECTOR FOR TREATMENT OF GLOBOID CELL LEUKODYSTROPHY
-
批准号:6116208
-
项目类别:
-
资助金额:$16.14万
-
财政年份:1999
-
负责人:GARY B BASKIN
-
依托单位:
ANIMAL MODEL OF GLOBOID CELL LEUKODYSTROPHY IN RHESUS MONKEYS: LYSOSOMAL STORAGE
-
批准号:6116204
-
项目类别:
-
资助金额:$16.14万
-
财政年份:1999
-
负责人:GARY B BASKIN
-
依托单位:
DEVELOPMENT OF RHESUS MODEL FOR HCV INFECTION: HEPATITIS
-
批准号:6116206
-
项目类别:
-
资助金额:$16.14万
-
财政年份:1999
-
负责人:GARY B BASKIN
-
依托单位:
ANIMAL MODEL FOR GENE THERAPY OF INHERITED DISORDERS
-
批准号:2908668
-
项目类别:
-
资助金额:$57.5万
-
财政年份:1999
-
负责人:GARY B BASKIN
-
依托单位:
ANIMAL MODEL FOR GENE THERAPY OF INHERITED DISORDERS
-
批准号:6188461
-
项目类别:
-
资助金额:$50.38万
-
财政年份:1999
-
负责人:GARY B BASKIN
-
依托单位:
ANIMAL MODEL OF GLOBOID CELL LEUKODYSTROPHY IN RHESUS: KRABBES DISEASE
-
批准号:6277433
-
项目类别:
-
资助金额:$10.02万
-
财政年份:1998
-
负责人:GARY B BASKIN
-
依托单位:
DEVELOPMENT OF PRECLINICAL MODEL FOR GENE THERAPY USING CD34+ STEM CELLS
-
批准号:6247290
-
项目类别:
-
资助金额:$6.02万
-
财政年份:1997
-
负责人:GARY B BASKIN
-
依托单位:
IMMUNOSUPPRESSION IN PROLONGING TRANSGENE EXPRESSION: CYSTIC FIBROSIS
-
批准号:6247291
-
项目类别:
-
资助金额:$6.02万
-
财政年份:1997
-
负责人:GARY B BASKIN
-
依托单位:
PRECLINICAL STUDIES OF LIVER DIRECTED GENE THERAPY IN NON HUMAN PRIMATES
-
批准号:6247289
-
项目类别:
-
资助金额:$6.02万
-
财政年份:1997
-
负责人:GARY B BASKIN
-
依托单位:
ANIMAL MODEL OF GLOBOID CELL LEUKODYSTROPHY IN RHESUS MONKEYS
-
批准号:6247288
-
项目类别:
-
资助金额:$6.02万
-
财政年份:1997
-
负责人:GARY B BASKIN
-
依托单位:
AAV AS VECTOR FOR TREATMENT OF GLOBOID CELL LEUKODYSTROPHY
-
批准号:6311755
-
项目类别:
-
资助金额:$14.73万
-
财政年份:1978
-
负责人:GARY B BASKIN
-
依托单位:
ANIMAL MODEL OF GLOBOID CELL LEUKODYSTROPHY IN RHESUS MONKEYS
-
批准号:6311753
-
项目类别:
-
资助金额:$14.73万
-
财政年份:1978
-
负责人:GARY B BASKIN
-
依托单位:
PATHOBIOLOGY OF SIV/DELTA INFECTION IN RHESUS MONKEYS
-
批准号:3107910
-
项目类别:
-
资助金额:$129.79万
-
财政年份:1978
-
负责人:GARY B BASKIN
-
依托单位:
OPPORTUNISTIC INFECTION W/ CLASS I & CLASS II MHC TYPE: SIV: RHESUS MONKEY
-
批准号:5219835
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:GARY B BASKIN
-
依托单位:--
ANIMAL MODEL OF GLOBOID CELL LEUKODYSTROPHY IN RHESUS MONKEYS
-
批准号:5219834
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:GARY B BASKIN
-
依托单位:--
DEVELOPMENT OF PRECLINICAL MODEL FOR GENE THERAPY USING CD34+ STEM CELLS
-
批准号:5219837
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:GARY B BASKIN
-
依托单位:--
PRECLINICAL STUDIES OF LIVER DIRECTED GENE THERAPY IN NON HUMAN PRIMATES
-
批准号:5219836
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:GARY B BASKIN
-
依托单位:--
海外基金